Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Profound Medical Corp (TSX: PRN )

10.23 +0.20 (+1.99%)
Streaming Delayed Price Updated: 3:59 PM EST, Dec 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Profound Medical Corp

< Previous 1 2 Next >
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Third Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
The first of the TULSA AI modules, Thermal Boost enables predictable, customized ablation at the prostate capsule 
From Profound Medical Corp.
Via GlobeNewswire
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Second Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Upcoming Investor Events
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Annual and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces First Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
Company confirms Current Procedural Terminology (“CPT®”) Category 1 application for TULSA 
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Present at the 43rd Annual Cowen Health Care Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Present at the 2022 Jefferies London Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Third Quarter 2022 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.